Sarah Parkinson

Photo of Sarah Parkinson
Senior Analyst
Cambridge Office

Education

M.S. in social policy, University of Pennsylvania; B.A. in cultural anthropology, University of Pennsylvania

Media Resources

This researcher is available for interviews.

To arrange an interview, contact RAND Europe Media Relations at +44 (1223) 353 329, x2560, or email europeanmedia@rand.org.

More Experts

Overview

Sarah Parkinson is a senior analyst at RAND Europe in the health and wellbeing group. She works across a range of topics, including public health, health services and health innovation research. Her recent work includes studies on the promotion of novel tobacco products, the future of antimicrobial resistance (AMR), financing of medicines R&D, and the use of new technologies for infectious disease prevention, surveillance and control. She is experienced in qualitative and quantitative methods, evaluations and futures research, and and has extensive experience managing projects for various UK government bodies, international clients and EU institutions.

Prior to joining RAND Europe, Parkinson worked on projects related to prescription opioids and prescription drug monitoring programmes in the US. She holds an M.Sc. in Social Policy from the University of Pennsylvania, and a B.A. in Cultural Anthropology from the same university.

Recent Projects

  • Future-proofing study of EU One Health AMR Action Plan
  • Study on smoke-free environments and advertising of tobacco and related products
  • Point of care technologies for infectious diseases
  • Understanding the financial ecosystem surrounding the development of medicinesFinancing of
  • Assessing the impact of developments in genetic testing on insurers' risk exposure

Selected Publications

Parkinson S, Smith J, Sidhu M, "Early development of primary care networks in the NHS in England: a qualitative mixed-methods evaluation," BMJ Open, 11(e055199), 2021

Hocking L, George J, Broberg EK, Struelens MJ, Leitmeyer KC, Deshpande A, Parkinson S, Francombe J, Morley KI, de Carvalho Gomes H, "A Scoping Review of Point-of-Care Testing Devices for Infectious Disease Surveillance, Prevention and Control," European Centre for Disease Prevention and Control , 2022

Morley KI, Parkinson S, Hocking L, Nederveen F, Hulme S, Evans H, "Study on Smoke-Free Environments and Advertising of Tobacco and Related Products: Final Report," European Commission, Tobacco Studies , 2021

Rodriguez-Rincon D, Parkinson S, Hocking L, Evans H, Hudson E, Morley KI, Assessing the impact of developments in genetic testing on insurers' risk exposure, RAND Corporation

Marjanovic S, Parkinson S, Francombe J, Romanelli RJ, Rodriguez-Rincon D, Manville C, Progress Report: AMR Industry Alliance 2021 Survey, AMR Industry Alliance , 2022

Smith J, Parkinson S, Harshfield A, Sidhu M, Early Evidence of the Development of Primary Care Networks in England, Published in: National Institute for Health Research, 2020

Parkinson S, Bousfield J, Millar R, George J, Marjanovic S, Communicating research evidence to boards in health and care organisations: A scoping study, RAND Corporation, 2021

Parkinson S, Francombe J, Stevenson C, Evans H, Deshpande A, Guthrie S, Wellcome Sanger Institute and Wellcome Genome Campus Landscape Review, RAND Corporation, 2021

Languages

Spanish

Commentary

  • Illustrated figures with information going between their open heads, photo by exdez/Getty Images

    Commercialisation and Open Science Do Not Have to Be Uneasy Bedfellows

    On the surface, tension exists between commercialization and open science approaches to research. But the two approaches are not irreconcilable--they can exist in harmony and complement one another to generate greater impact from investments in research and innovation.

    Aug 6, 2021 Research Professional News

  • Senior woman using digital tablet and having video call with nurse, photo by izusek/Getty Images

    Primary Care Networks in a Time of Pandemic

    Primary care networks in the UK bring together general practices and community providers to develop new services for patients and to provide better integration of health and social care services and sustainability in primary care. While still relatively new, their trajectory is likely to be influenced by COVID-19–related adaptations they have made over the course of the pandemic.

    Nov 11, 2020 GP Life

Publications